Compound Report Overview
Compound Name:
MEPAZINE
Compound Identifier:
701133
Mol Structure 2D:
701133
Molecular Weight:
310
Formula:
C19 H22 N2 S
Development Status:
Withdrawn by FDA
SMILES:
CN1CCCC(CN2c3ccccc3Sc4ccccc24)C1
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| MEPAZINE | 80 | Adrenergic alpha1A | View |
| MEPAZINE | 167 | Muscarinic M1 | View |
| MEPAZINE | 81 | Adrenergic alpha1B | View |
| MEPAZINE | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| MEPAZINE | 168 | Muscarinic M2 | View |
| MEPAZINE | 82 | Adrenergic alpha1D | View |
| MEPAZINE | 85 | Adrenergic alpha2B | View |
| MEPAZINE | 626 | Histamine H1, Central | View |
| MEPAZINE | 213 | Sigma1 | View |
| MEPAZINE | 92 | Adrenergic, Norepinephrine Transporter | View |
| MEPAZINE | 84 | Adrenergic alpha2A | View |
| MEPAZINE | 205 | Serotonin 5-HT2B | View |
| MEPAZINE | 114 | Dopamine D2L | View |
| MEPAZINE | 86 | Adrenergic alpha2C | View |
| MEPAZINE | 620 | Calcium Channel Type L, Benzothiazepine | View |
| MEPAZINE | 182 | Opiate kappa | View |
| MEPAZINE | 212 | Serotonin Transporter | View |
| MEPAZINE | 121 | Dopamine Transporter | View |
| MEPAZINE | 151 | Imidazoline I2, Central | View |
| MEPAZINE | 628 | Melanocortin MC5 | View |
| MEPAZINE | 214 | Sigma2 | View |
| MEPAZINE | 210 | Serotonin 5-HT6 | View |
| MEPAZINE | 116 | Dopamine D3 | View |
| MEPAZINE | 216 | Sodium Channel, Site 2 | View |
| MEPAZINE | 206 | Serotonin 5-HT2C | View |
| MEPAZINE | 148 | Histamine H2 | View |
| MEPAZINE | 643 | CYP450-2D6 Inhibition | View |
| MEPAZINE | 171 | Muscarinic M5 | View |
| MEPAZINE | 204 | Serotonin 5-HT2A | View |
| MEPAZINE | 170 | Muscarinic M4 | View |
| MEPAZINE | 169 | Muscarinic M3 | View |
| MEPAZINE | 140 | Glutamate, NMDA, Agonism | View |
| MEPAZINE | 631 | Protein Serine/Threonine Kinase, ERK2 | View |
| MEPAZINE | 117 | Dopamine D4.2 | View |